Brief: Catalyst Pharmaceuticals Announces Health Canada’S Acceptance Of Agamree® New Drug Submission
08/04/2025 14:31
April 8 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O: CATALYST PHARMACEUTICALS ANNOUNCES HEALTH CANADA’S ACCEPTANCE OF AGAMREE® NEW DRUG SUBMISSION WITH PRIORITY REVIEW FOR SUB-LICENSEE KYE PHARMACEUTICALS Source text: ID:nGNXySmCm Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))